Raritan, N.J. – May 13, 2010 — iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Cornerstone Therapeutics Inc.®, a pharmaceutical company specializing in the respiratory and related markets, has gone live on solutions from iContracts to manage critical processes including chargebacks, rebates, Medicaid, and government pricing compliance. The entire suite of products is based on iContracts’ Better Contracting Solutions (BCS) platform, available on-demand or behind-the-firewall, and will assist Cornerstone Therapeutics manage their broad portfolio of products in a unified environment with a high degree of automation.
Donna Forbes White, Director of Commercial and Business Analytics with Cornerstone Therapeutics, noted “Our experience with iContracts’ products and people has been very positive. The iContracts alternative has provided us with a customized tool that is easy to use and provides a quick return on our investment. iContracts’ vision, platform and, most importantly, their focus on client success has allowed for rapid implementation and has positioned Cornerstone to ably manage these critical processes as we continue to grow.”
“The engagement of the Cornerstone team and their commitment to each and every step in the process paved the way for an extremely successful implementation that is already delivering value and insuring that Cornerstone is well positioned for growth with highly automated systems and processes to insure payment accuracy and compliance across the spectrum of contracts and government programs,” commented A. Leigh Powell, Chief Executive Officer of iContracts.
iContracts solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’ revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic screen formats. This groundbreaking design drastically reduces implementation; training and future upgrade timeframes and costs.
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with more experience in building contract management solutions for the Life Sciences industry than anyone on the planet! This deep understanding and straightforward approach shows in everything we do. iContracts comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Cornerstone Therapeutics
Cornerstone Therapeutics Inc. (Nasdaq: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with a recent regulatory submission filing and four additional regulatory approval submissions targeted within the next three years. Key elements of the Company’s strategy are to in-license or acquire rights to under promoted, patent-protected, branded respiratory or related pharmaceutical products, or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company’s currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company’s specialty sales force which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company’s currently marketed products, newly acquired products and product candidates. For more information, please visit www.crtx.com.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com